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ETA-mediated Ca2 signaling in thin descending limbs of Henle’s Since the original discovery of endothelins (ET) as
loop: Impairment in genetic hypertension. potent vasoconstrictors, there is now increasing evidence
Background. Endothelins (ET) have diuretic and natriuretic to show that they also have significant diuretic and natri-actions via ETB receptors that are found in most renal tubular
uretic actions [1]. In addition, they appear to work as localsegments, although the thin limbs have not been studied. Data
(rather than circulating) hormones, inhibiting salt andalso suggest that dysfunction of the renal ET system may be
important in the pathogenesis of hypertension. The present water reabsorption through a paracrine and/or autocrine
study was aimed at determining the presence and nature of action on renal tubular cells [2]. Although it is still uncer-
ET receptors in the thin limbs of Henle’s loop and their ability
tain whether the renal ET system is involved in the regu-to activate a Ca2-dependent signaling pathway, as well as
lation of sodium and water balance under normal condi-whether ET-induced Ca2 signals are altered in hypertension.
Methods. Reverse transcription-polymerase chain reaction tions [3], data suggest that it might play a primary role
(RT-PCR) and Fura 2 fluorescence measurements of [Ca2]i in some pathologic settings. Thus, in rats treated with
were made to characterize ET receptors in descending thin salt and deoxycorticosterone acetate (DOCA), urinarylimbs (DTL) of Sprague-Dawley rats, spontaneously hyperten-
excretion of ET-1 (which reflects renal synthesis) increasessive (SH) rats, and control Wistar-Kyoto (WKY) rats, and
in parallel with urinary excretion of sodium and water [4],the three selected strains of Lyon rats with low-normal (LL),
normal (LN), and high (LH) blood pressure. as do renal tissue levels of ET-1, ET-converting enzyme
Results. In SD rats, ET induced Ca2 signals in DTL of long- activity and the number of ETB receptors in renal medul-looped nephrons, but not in DTL of short loops, or in ascending
lary tissue [4, 5]. Conversely, pharmacologic blockadethin limbs. Ca2 increases were abolished by BQ123, an antago-
of the ETB receptor [6], the subtype usually expressednist of the ETA receptor, but not by BQ788, an antagonist of
the ETB subtype. Endothelin-3 and sarafotoxin 6c, two ETB by renal epithelium [2], as well as targeted [7] or partial
receptor agonists, were both inactive. RT-PCR showed the [8] deletion of the ETB receptor gene, have been shown
presence of both ETA and ETB receptor mRNA. Ca2 signals to cause salt retention and hypertension. Moreover, de-measured in DTL of WKY LL and LN rats were similar to
creased urinary ET-1 excretion has been found in salt-those in Sprague-Dawley rats, but were significantly diminished
sensitive hypertensive subjects [9], and decreased synthe-(LH) or abolished (SH) in hypertensive rats.
Conclusion. A functional ETA receptor activating a Ca2- sis of ET-1 in renal papilla has also been demonstrated
dependent pathway is expressed in DTL. This ETA-induced in different strains of spontaneously hypertensive (SH)
calcium signaling is impaired in two strains of genetically hyper-
rats [10–12]. Taken together, these findings support thetensive rats.
concept that locally synthesized ET-1 and medullary ETB
receptors may serve to aid control of arterial blood pres-
sure by promoting salt and water excretion; therefore,
disorders of the renal ET-1 system could be important
in the mechanisms underlying hypertension and salt sen-
Key words: endothelin, ETA receptor-mediated Ca2 signaling, ETA sitivity.and ETB receptor mRNA, type II descending thin limb, genetic hyper-
tension. Because the inner medullary collecting duct (IMCD)
is the main site of ET-1 synthesis [13], and it is also the
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and its effects are not restricted to the IMCD. Evidence was perfused via the renal artery with 5 mL HEPES-
for ET-1 mRNA [13], as well as ETB receptor mRNA [14] buffered saline solution (HBSS; containing 140 mmol/L
and binding sites [15], has been found in most nephron NaCl, 5 mmol/L KCl, 0.8 mmol/L MgSO4, 0.33 mmol/L
segments. ET-1 has also been shown to inhibit water Na2HPO4, 0.44 mmol/L NaH2PO4, 1.0 mmol/L MgCl2, 1
and/or sodium reabsorption in the proximal tubule [16], mmol/L CaCl2, 10 mmol/L HEPES, and 5 mmol/L glucose,
the thick ascending limb of Henle’s loop [17, 18], the pH 7.4), followed by the same volume of a 0.16% collagen-
cortical portion of the collecting duct [19], and in the ase solution (from Clostridium histolyticum; Serva, Boeh-
IMCD [20]. This suggests that the diuretic and natriuretic ringer Mannheim, Meylan, France). Thin corticomedul-
effects of ET-1 found in vivo may originate from ET-1 lary slices were then incubated in 0.12% collagenase
actions at different sites along the nephron. solution for 20 minutes at 30C, carefully rinsed, and trans-
Despite the wide expression of ET receptors, no pub- ferred into microdissection medium [HBSS to which 0.1%
lished studies have reported whether or not the thin bovine serum albumin (BSA) had been added] for har-
limbs of Henle’s loop are also functional targets for ETs. vesting tubule segments at 4C. All tubule samples were
Preliminary experiments from our laboratory have shown stored in a droplet of microdissection medium (2 L) at
that basolateral ET-1 increases cytosolic calcium concen- 0 to 4C until use.
tration ([Ca2]i) in the descending thin limb (DTL), indi- The following structures were studied: DTL of super-
cating the presence of functional receptors in this seg- ficial and juxtamedullary nephrons (type I and type II
ment. The DTL plays an important role in the regulation epithelium, respectively); outer medullary collecting ducts
of sodium and water excretion by the kidney. First, it (OMCD) and IMCD, as well as thin ascending limbs
participates in establishing the corticomedullary osmotic (ATL) and glomeruli. DTL and OMCD were both iso-
gradient. Second, it is an active site of prostaglandin E2 lated from the inner stripe of outer medulla. Type I DTL
synthesis [21–23], a prostanoid that may induce natriure- were identified anatomically by their attachment to the
sis by inhibiting salt reabsorption in the neighboring end of superficial nephron proximal straight tubules and
thick ascending limb. Therefore, the aim of the present functionally by the inability of 8-arginine vasopressin
study was to use a functional and molecular approach to generate calcium signals [26]. Type II DTL of deep
to (1) characterize the ET receptors expressed in DTL; nephrons were identified by their larger diameter and
and (2) examine whether ET receptors and ET’s effect typical morphologic appearance under the stereomicro-
on [Ca2]i would be altered in DTL and collecting ducts scope. ATL were microdissected in inner medulla. They
of hypertensive rats. were identified anatomically by their attachment to the
end of medullary thick ascending limbs, and functionally
METHODS by their ability to respond to 8-arginine vasopressin by
generating calcium signals [26].Animals
In a first set of experiments, ET-1 effects have been Expression of type A (ETA) and type B (ETB)
analyzed in normal adult male Sprague-Dawley rats (Har- endothelin-receptor mRNA
lan, Gannat, France). In a second set of experiments, its
RNA was extracted from pools of 20 to 50 microdis-effects have been studied in two different models of ge-
sected nephron segments as described previously [27]netic hypertension: the SH rats/Kyoto model, derived
and summarized below. The pools of tubules were trans-from the Wistar strain (group 1), and the Lyon model,
ferred with 10 L microdissection solution into 400 Lderived from the Sprague-Dawley strain (group 2). In
denaturing solution [4 mol/L guanidium thiocyanate, 25group 1, experiments were carried out on male prehyper-
mmol/L sodium citrate (pH 7.0), 0.1 mol/L -mercapto-tensive (3 to 5 weeks old) [24], and hypertensive (8 to 10
ethanol, and 0.5% sarcosyl) and 20 g yeast tRNA usedweeks old) rats, and on age-matched Wistar-Kyoto (WKY)
as carrier. After phenol/chloroform extraction and iso-controls. In group 2, male rats of the three simultane-
propyl alcohol precipitation, the final RNA pellet wasously selected Lyon strains [25] with high, normal, and
dried under vacuum and dissolved in RNA dilution bufferlow-normal blood pressure were studied (all aged 10 to
(10 mmol/L Tris, pH 7.6, 1 mmol/L ethylenediaminetetra-12 weeks). In some animals, indirect measurements of
acetic acid (EDTA), 2 mmol/L dithiothreitol, and 40 U/mLsystolic blood pressure were made by the tail-cuff method
ribonuclease inhibitor (Rnasin, Promega, Charbonnie`res,2 days before study.
France). The yield of this RNA extraction procedure isAll animals were fed a standard laboratory diet (UAR,
90% [27].Epinay, France; 2.5 g Na/kg) with free access to water
Expression of mRNA encoding ETA and ETB recep-until the day of study.
tors was assessed by reverse transcription-polymerase
Isolation of nephron segments chain reaction (RT-PCR), using the following specific
primers [15]: ETA-receptor sense (5-GTGTTTAAGCThe left kidney of sodium pentobarbital-anesthetized
rats (Nembutal; 50 mg/kg body weight, intraperitoneally) TGTTGGCGGG-3), and anti-sense (5-CGAGGTCA
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TGAGGCTTTTGG-3), bases 405 to 424 and 1172 to ether)-N,N,N,N-tetraacetic acid (for the minimal ratio)
or 3 mmol/L Ca2 (for the maximal ratio).1191 from the initiating ATG codon, respectively, and
ETB-receptor sense (5-AGCTGGTGCCCTTCATAC
ChemicalsAGAAGGC-3), and antisense (5-TGCACACCTTTC
CGCAAGCACG-3), bases 521 to 545 and 1418 to 1439, ET-1, ET-3, sarafotoxin 6c, 8-arginine vasopressin, and
norepinephrine (arterenol, bitartrate salt) were purchasedrespectively. RT was carried out for 2 hours at 37C in
a final volume of 10 L in the presence of RNAs from from Sigma (Saint Quentin Fallavier, France). Other com-
pounds were from Merck Eurolab (Fontenay-sous-Bois,1 mm tubular length, random primers (PdN6, 5 mol/L,
Roche Diagnostics, Meylan, France), dNTPs (500 mol/L) France).
and SuperscriptTM II reverse transcriptase (100 U, In-
Statisticsvitrogen, Ltd., Paisley, UK). After denaturation at 95C
for 30 seconds, PCR was carried out in the same tube Results are given as mean  SE. Mean values from
different groups were compared according to either un-in a final volume of 100 L after addition of the sense
and antisense primers (10 pmol), and Taq polymerase paired Student t test, or, when comparing more than two
groups together, according to ANOVA (analysis of vari-(1.25 U, Eurobio, Les Ulis, France). Samples were sub-
mitted to 30 to 35 cycles of three temperature steps: 94C, ance) test with protected least significant difference
(PLSD) Fisher test.30 seconds; 60C, 30 seconds; 72C, 1 minute, except for
the last cycle in which the elongation lasted 10 minutes.
The DNA fragments were separated by electrophoresis
RESULTS
on a 1.5% (wt/vol) agarose gel containing 10 g/mL
Functional evidence for ET receptors in type II DTLsethidium bromide, and visualized under ultraviolet illu-
mination. For both ETA and ETB receptors, the nature The representative trace, as well as calculated mean
data in Figure 1 A and B, show that basolaterally super-of the PCR product (787 and 919 bp expected size, re-
spectively) was confirmed by sequencing. In all experi- fused ET-1 (1 to 100 nmol/L) induced dose-dependent
[Ca2]i increases in type II DTL The calcium responsements, possible contamination was checked by control
RT-PCR reactions on samples in which reverse tran- was sustained at 1 nmol/L, but transient at 100 nmol/L,
returning spontaneously to basal levels under hormonescriptase had been excluded from the reverse transcrip-
tion mixture (RTase ). stimulation. At 10 nmol/L, the pattern of the response
was more variable, showing either moderate, slow, and
Measurement of intracellular free-calcium ([Ca2]i) sustained [Ca2]i increases (	[Ca2]i 
200 nmol/L; Fig.
1A), which resembled those observed in the OMCD[Ca2]i was measured using the method previously de-
scribed [28]. Each tubular segment was loaded with Fura (Fig. 1C); or high and sharp transients, such as those
obtained at 100 nmol/L ET-1 (	[Ca2]i 200 nmol/L;2-AM (Molecular Probes, Interchim, Asnie`res, France;
10 mol/L in microdissection medium) for 1 hour at Fig. 1D, left). The effect of ET-1 persisted when Ca2
was removed from superfusion medium (mean 	[Ca2]iroom temperature and subsequently transferred to a su-
perfusion chamber, where the ends of the segment were in Ca2-free medium, 233  40 nmol/L above basal, N 
8, Fig. 1D, right).aspirated into two glass holding pipettes (to prevent pos-
sible perfusion of the luminal membrane). The segment No response could ever be obtained in either type I
DTL (Fig. 2A) or ATL (Fig. 2B), even though thesewas then superfused at a rate of 10 mL/min with HBSS
for a 5-minute equilibration period. Fura 2 fluorescence segments did respond to extracellular adenosine triphos-
phate (ATP) and vasopressin (AVP) (Table 1), as antici-was measured in a tubular portion of 20 to 30 cells using
a standard photometric setup (model MSP 21, Zeiss, pated from previous studies [26].
Jena, Germany) during superfusion with either HBSS
Pharmacologic characterizationalone or the same solution to which agonists had been
added. All solutions were stored in individual reservoirs To determine which ET receptor subtype is involved
in the generation of calcium signals, we tested the effectat room temperature until use; the temperature was
raised to 37C just prior to entry to the perfusion chamber. of different agonists and antagonists specific for either
the ETA or the ETB subtype on DTL. Because theFollowing subtraction of tubular autofluorescence from
the fluorescence intensities of Fura 2 at 340 and 380 nm, OMCD is known to contain ETB receptors [14, 15], it
was also tested, as a control, in the same experiments.[Ca2]i was calculated from the equation of Grinkievicz,
Poenie, and Tsien [29], using a dissociation constant of As shown in Figure 3 A and B, BQ788, a specific ETB
receptor antagonist, did not change [Ca2]i on its ownFura 2 for calcium of 224 nmol/L. The calibration param-
eters were determined from internal calibration using a and did not alter the effect of ET-1 in DTL (Fig. 3A).
In contrast, it almost completely abolished the responsesolution containing 10 mol/L ionomycin and both 0
Ca2 and 1 mmol/L ethylene glycol bis(-aminoethyl- to ET-1 in OMCD (Fig. 3B). Conversely, BQ123, a spe-
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Fig. 2. Effect of basolaterally superfused endothelin 1 (ET-1) (10 nmol/L)
on [Ca2]i in the descending thin limb of short loop nephrons (type I
DTL) (A ) and in the ascending thin limb (ATL) (B ). ET-1 is devoid
of effect in type I DTL and in ATL even though these segments respond
to other activators of phospholipase C, as expected from previous stud-
ies [26]. Abbreviations are: AVP, 100 nmol/L 8-arginine vasopressin;
ATP, 100 mol/L adenosine triphosphate.
Fig. 1. Dose-dependent [Ca2]i increases induced by basolateral super-
fusion of endothelin 1 (ET-1) in thin descending limbs of long-looped
Table 1. Endothelin-1–induced Ca2 signals in thin descendingnephrons (type II DTL). (A ) Representative trace. (B ) Mean increases
limbs (DTL) of the rat Henle’s loop(peak-basal)  SE calculated for each ET-1 concentration from several
tubules (number in parenthesis). Data obtained from four rats. (C )
	[Ca2]i nmol/LControl response obtained in the outer medullary collecting duct
(OMCD). (D ) Response of type II DTL in the presence (left) and Segment ET-1 AVP ATP
absence (right) of calcium in extracellular medium.
DTL type I 124 (9) NT 77182 (8)
DTL type II 22519 (7) 11 (7) NT
ATL 32 (4) 430153 (4) NT
Values are mean [Ca2]i increases (peak-basal) SE induced by basolaterally
cific ETA receptor antagonist, blocked the ET-1 effect superfused endothelin 1 (10 nmol/L ET-1) in thin descending (type I and type
II DTL) and ascending limbs (ATL) from Sprague-Dawley rat kidneys (fouron DTL and was devoid of effect on OMCD (Fig. 3 C
rats; number of tubules in parentheses). Where necessary, 8-arginine vasopressin
and D). In support of these observations, ET-3 and sara- (AVP; 100 nmol/L) or adenosine-5-triphosphate (ATP; 100 mol/L) was tested
as controls on the same tubules. NT is not tested.fotoxin 6c, two agonists specific for the ETB receptor,
were inactive on DTL (Fig. 4 A and C) and active on
OMCD, where they generated calcium signals compara-
ble in magnitude to those elicited by ET-1 (Fig. 4 B and OMCD was used because it is a good marker of the ETB-
D). Mean values for these experiments are reported in receptor subtype (Figs. 3 and 4); IMCD and glomerulus
Table 2. were used because they have been reported to express
both subtypes [14, 30, 31]. As shown by the results, clear
Molecular characterization signals for both ETA and ETB receptors were found in
Experiments have been carried out to investigate glomerulus and DTL. In contrast, OMCD and IMCD
whether ETA receptor mRNA is expressed in DTL, as expressed exclusively mRNA for the ETB receptor.
suggested by functional data (Figs. 3 and 4). Figure 5
Altered response to ET-1 in SH ratsillustrates the results of one RT-PCR experiment (repre-
sentative of four others) in which ETA and ETB receptor Several defects of the renal medullary ET system have
expression were studied in parallel on the same mRNA been associated with hypertension [9–12]. Therefore, we
examined whether calcium responses of DTL and OMCDextracts from DTL, OMCD, IMCD, and glomerulus;
Bailey et al: ETA-induced Ca 2 signaling in type II DTL1280
Fig. 3. Effect of specific antagonists of the ETA and ETB receptor
subtypes on calcium responses to basolateral endothelin 1 (ET-1) in Fig. 4. Effect of endothelin 3 (ET-3) and sarafotoxin 6c (S6C), two
thin descending limbs (DTL) (A and C ) of long-looped nephrons and agonists specific for the ETB receptor subtype, on [Ca2]i in type II thin
outer medullary collecting ducts (OMCD) (B and D ). (A and B) Effect descending limbs (DTL) (A and C) and outer medullary collecting ducts
of BQ788, a specific ETB receptor antagonist. (C and D) Effect of (OMCD) (B and D). ET-1, ET-3 and S6C (all 10 nmol/L) were applied
BQ123, a specific ETA receptor antagonist. BQ123 or BQ788 (10 to the basolateral side of tubules.
nmol/L) were added to the bath 2 to 3 minutes before ET-1 (10 nmol/L).
Where necessary, 8-arginine vasopressin (AVP; 100 nmol/L) and adeno-
sine triphosphate (ATP; 100 mol/L) were used as control of tubule
viability in OMCD and DTL, respectively.
Table 2. Pharmacologic characterization of the endothelin-receptor
subtypes eliciting calcium signals in thin descending limb (DTL)
and outer medullary collecting duct (OMCD)
to ET-1 would be altered in SH rats and Lyon hyperten- 	[Ca2]i nmol/LExperimental
sive rats. condition DTL OMCD
SH rats and their control WKY rats were studied at
ET-1 12820 (18) 9216 (6)
either 3 to 5 weeks old, before the onset of hypertension ET-3 0 (10) 9612 (6)
S6c 0 (6) 9310 (4)[24], or aged 8 to 10 weeks old, when hypertension is
ET1  BQ788 12019 (12) 85 (9)established. Mean arterial blood pressures in the older
ET1  BQ123 0 (7) 876 (4)
age group were 170  6 and 127  7 mm Hg (N  4)
Values are mean [Ca2]i increases (peak-basal)  SE, calculated in eachin SH rats and WKY rats, respectively; P 
 0.001. condition from several tubules (type II DTL and OMCD; number in parentheses)
obtained from at least four rats. ET-1, ET-3, 10 nmol/L endothelin 1 and 3,Lyon rats from the three simultaneously selected
respectively; S6c, 10 nmol/L sarafotoxin 6c; BQ788 (an ETB-receptor antagonist)strains referred to as low-normal, normal, and high blood and BQ123 (an ETA-receptor antagonist), each used at 10 nmol/L, were added
to the superfusion medium 2 to 3 minutes before ET. Note that the response ofpressure were studied at 10 to 12 weeks old. Mean arte-
DTL to ET-1 (with and without BQ) was of low magnitude as compared with
rial blood pressures were 120  13, 131  3, and 166  those obtained in the other experimental series (see Fig. 1 and Table 1).
8 mm Hg (N  4), respectively. The mean arterial blood
pressure of high blood pressure rats was significantly
higher than that of both low-normal (P 
 0.005) and
DTL. This decreased response of DTL could already benormal rats (P 
 0.02), whereas that of low-normal rats
observed in 3- to 5-week-old animals. It was specific forwas not significantly different from normal rats. There-
ET-1, as the response to norepinephrine was similar tofore, as reported previously [25], Lyon rats with high
that of WKY rats in the same experiments. Finally, itblood pressure can be compared with two genetically
did not result from a transcriptional defect, since ETAdistinct strains of control rats (low-normal and normal).
and ETB-receptor mRNAs were both expressed in theAs illustrated by Figure 6, in 8- to 10-week-old SH
DTL of SH rats (Fig. 7).rats, the calcium response to 10 nmol/L ET-1 was normal
in OMCD, whereas it was blunted by about 90% in In the Lyon strain, the calcium responses (peak-basal)
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Fig. 5. Sample gels from one reverse tran-
scription-polymerase chain reaction (RT-PCR)
experiment (35 cycles). The relative expression
of ETA and ETB receptor mRNA in glomerulus
(Glom), type II thin descending limb (DTL),
outer medullary collecting duct (OMCD) and
inner (IMCD) medullary collecting duct. 
and are samples assayed in the presence and
absence of reverse transcriptase, respectively.
For each sample, 3L mRNA extract was used
(the mRNA extracted from 1 glomerulus or
1 mm tubule length). ETA and ETB receptor
mRNAs were looked for in the same extracts.
Fig. 6. Endothelin 1 (ET-1)–induced [Ca2]i increases (peak-basal) in
thin descending limb (DTL) and outer medullary collecting duct (OMCD) Fig. 7. Sample gels from one reverse transcription-polymerase chain
reaction (RT-PCR) experiment (representative of two others). Theof spontaneously hypertensive (SHR) and control Wistar-Kyoto (WkY)
rats. (A ) Data obtained in 8- to 10-week-old rats. (B ) Data from 3- to expression of ETA and ETB-receptor mRNA in the thin descending
limb (DTL) of the same spontaneously hypertensive rat (SHR) is shown.5-week-old (prehypertensive) rats. In each experiment, one SHR ( )
and one age-matched WkY rat () were studied in parallel. Values are In each experiment, a Wistar-Kyoto (WKY) rat was also tested as positive
control.  and  are samples assayed in the presence and absence ofmeans  SE from several tubules (number in parentheses) obtained
from four rats in each group. *P 
 0.001 vs. WkY. ET-1 (10 nmol/L) reverse transcriptase, respectively. For each sample, 3 L mRNA ex-
tract were used (the mRNA extracted from 1 mm tubule length). Foror norepinephrine [1 mol/L norepinehrine (NEp)] were added to the
basolateral superfusion medium. Note that the response of DTL to both SHR and WKY rats, three different extracts were prepared and
tested in three separate experiments (30 cycles PCR each).norepinephrine was not altered in SHR.
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looped nephrons (Fig. 1), ET-1 elicits dose-dependent
[Ca2]i increases that are similar in hormone sensitivity
to those previously reported in the collecting duct [32]. As
in the collecting duct, the calcium response persists in Ca2-
free medium, suggesting that it is secondary to activation
of a phospholipase C–dependent pathway [33–35].
On the basis of published data, it is generally assumed
that the predominant ET receptor expressed in renal
epithelium is the ETB receptor. This conclusion is based
on a large body of experimental evidence obtained from
molecular and functional studies of microdissected neph-
ron segments. Such experiments have shown that ETB,
but not ETA, mRNA is expressed in the proximal tubule,
the thick ascending limb and the collecting duct [14],
and that ETB receptors account fully for the inhibitory
effects of ET-1 on sodium reabsorption in the thick as-
cending limb [17, 18], as well as on vasopressin-depen-
dent cAMP accumulation [31] and water reabsorption
[30] in the collecting duct. In proximal tubules, part of
the ET-1 effect on phospholipid signaling might also be
due to the presence of ETC receptors in the basolateral
membrane [36]. In contrast to these data, we have foundFig. 8. Endothelin 1 (ET-1)–induced [Ca2]i increases (peak-basal) in
that in the DTL of long-looped nephrons, both ETA andthin descending limb (DTL) of the normotensive (LN;) and hyperten-
sive (LH; ) strains of Lyon rat. All rats were 10 to 12 weeks old. ETB mRNA are present (Fig. 5), and that ET-1–induced
Values are means  SE from several tubules (number in parentheses) calcium signals are only linked to the ETA-receptor sub-obtained from five rats per group and per experimental condition. The
type (Figs. 3 and 4). Indeed, the calcium response to ET-1effects of 3 and 10 nmol/L ET-1 are compared. *P 
 0.02 vs. LN; **P 

0.001 vs. LN. was totally blocked by an ETA antagonist (Fig. 3), and
ETB agonists (ET-3 and sarafotoxin 6c) were devoid of
effect in the DTL (Fig. 4). If mRNA is translated into
functional ETB receptor protein, these data indicate thatto 10 nmol/L ET-1 were LL, 236  22 nmol/L (N  17);
the ETB receptor subtype in the DTL is linked to a cal-LN, 219  16 nmol/L (N  15); LH, 146  19 nmol/L
cium-independent signaling pathway, as shown previously(N  15), respectively. The calcium rise in the LH strain
in our laboratory for the mouse and rat thick ascendingwas significantly blunted compared with the LL (P 
limb [17].0.002) and LN (P  0.01) strains. Figure 8 compares the
Our data for OMCD (Fig. 5) are fully consistent withcalcium responses to 3 and 10 nmol/L ET-1 in the LN
those published already, in that ETB-receptor mRNAand LH strains. At 10 nmol/L, the impairment in LH
was clearly expressed, whereas ETA-receptor mRNA wasrats was only moderate at 33%, whereas at 3 nmol/L
barely detectable in the same extracts [15]. In supportit was greater, almost double at 66%, suggesting that
of these data, we found that an ETB, and not an ETA,the dose-response curve for Lyon rats with high blood
antagonist blocked the ET-1–induced calcium signalspressure is shifted to the right.
and that ETB agonists elicited them (Figs. 3 and 4).
Up to now, the ETA receptor subtype has been consid-
DISCUSSION ered as a vascular receptor, because it is particularly
abundant in vascular smooth muscle cells. In the kidneyThis paper reports for the first time that (1) ETA and
ETB receptor mRNA are expressed in the rat DTL of ETA-receptor mRNA and/or binding sites have been
found in renal vessels [37, 38], as might be expected,long-looped nephrons; (2) ETA, but not ETB, receptors
activate a Ca2-dependent signaling pathway, and (3) but also in intact glomeruli [14], cultured glomerular
mesangial cells [39], inner medullary interstitial cellsET-1–induced calcium signals are blunted in genetically
hypertensive rats. [38, 40], and (though to a lesser degree) in freshly pre-
pared suspensions of IMCD cells [30, 31]. This latterAs already mentioned, numerous studies have been
undertaken in the past to identify the sites of action of finding is at variance with the data presented here (Fig.
5) and with that of others who also failed to detect theET-1 along the nephron, its signaling mechanisms, and
the nature of its biologic effects on renal tubular cells. presence of mRNA specific for the ETA-receptor in mi-
crodissected IMCD [14]. However, although the cell sus-However, none of these studies has investigated the thin
limbs of Henle’s loop. Our data show that in DTL of long- pensions used to investigate ET receptors were highly
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purified, it is possible that the trace of ETA found in rats before the onset of hypertension (Fig. 6) suggests,
but does not prove, that it could in some way be involvedthese preparations was due to some contamination with
vascular and/or interstitial cells. Even if present in IMCD in the onset of hypertension. This possibility is at least
consistent with the many published examples demonstra-cells, ETA receptors do not account for any known effect
of ET-1 in this segment [30, 31]. In this respect, our ting that salt-dependent hypertension is associated with
disturbances of the hormonal mechanisms regulating saltstudy is the first to provide functional evidence for ETA
receptors in a renal tubular epithelial cell. and water reabsorption, for example, disorders in medul-
lary prostaglandin E2 synthesis [45], prostaglandin E2Data in Figure 2 and Table 1 show that ET-1 does
not alter [Ca2]i in the DTL of short-looped nephrons. action on the medullary thick ascending limb [46], as
well as genetic defects of the renin-angiotensin-aldoste-Because this type of DTL is difficult to isolate in the rat,
we did not investigate whether it expresses mRNA for rone and atrial natriuretic peptide systems [47].
At present, we do not know anything about the cellulareither the ETA or the ETB receptor. Therefore, we cannot
say if it lacks ET receptors, or expresses ET receptors events underlying the loss of ET-1 calcium signals in
the DTL. RT-PCR analysis of mRNA shows that ETA-linked to calcium-independent pathways.
It is known that DTL from short and long-looped receptor mRNA is expressed in DTL of both WKY rats
and SH rats (Fig. 7), as in normal Sprague-Dawley ratsnephrons are morphologically and functionally different.
The former are characterized by a flat type I epithelium (Fig. 5). Therefore, if the defect in the hypertensive
strains concerns the ETA receptor, it is not transcriptionalthat is permeable to urea, but almost impermeable to
sodium; whereas the latter exhibit a tall type II epithe- in origin. It might also involve a protein located down-
stream in the chain of events leading to phospholipaselium that is impermeable to urea, but permeable to so-
dium [41]. The nature of any biologic effect exerted by C activation, including phospholipase C itself, or another
protein coupling it to the ETA receptor. The fact that inET-1 on this type II epithelium is still unknown. ET-1
might alter the passive movements of sodium and water the same DTL the calcium response to norepinephrine
was preserved, but that to ET-1 abolished (Fig. 6), is inthat take place in this segment [41]. An alternative hy-
pothesis is that ET-1 stimulates the calcium-dependent keeping with the latter possibility.
synthesis of an arachidonic acid metabolite [prostaglan-
din E2, 20-hydroxyeicosatetraenoic acid (20-HETE), or CONCLUSION
others], as already demonstrated in different cell types
Our study provides the first evidence for a functionalfor ET and other activators of phospholipase C [31, 42].
ETA receptor in a native renal tubular epithelial cell.It is perhaps worth noting in this respect that type I
This receptor is specifically located in the DTL of long-DTL are located inside, or at the periphery of, vascular
looped nephrons. It triggers mobilization of intracellularbundles and close to descending vasa recta, whereas type
calcium upon binding to ET-1, probably as a result ofII DTL are located outside the bundles in close proximity
phospholipase C activation. Finally, ETA-dependent cal-to thick ascending limbs [43]. Thus, paracrine inhibition
cium signals in DTL are diminished, or abolished, inof sodium chloride reabsorption in the thick ascending
genetically hypertensive rats. Therefore, we speculate thatlimb as a result of ET-1–induced eicosanoid synthesis in
this novel defect in the medullary ET system may havetype II DTL could be one of the mechanisms by which
some role in disordered renal sodium and water han-ET-1, via its ETA receptors, exerts a diuretic and natri-
dling, and thus contribute to the onset of hypertension.uretic effect [44].
The calcium responses to ET-1 in type II DTL have
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